← All trials
NCT04340297
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2020
- Primary completion
- Dec 1, 2021
- Completion date
- Dec 31, 2021
- First posted
- Apr 9, 2020
- Last posted
- Apr 9, 2020
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- Tianjin University of Traditional Chinese MedicineCollaborator
- China Academy of Chinese Medical SciencesOverall official - principal investigator
- Huazhong University of Science and TechnologyCollaborator
- Guangxi Medical UniversityCollaborator
- Guangdong Provincial Hospital of Traditional Chinese MedicineCollaborator
- Jiangsu UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.